CYCLOSPORIN IN JUVENILE DERMATOMYOSITIS

The Lancet

Volumn 333, Issue 8646, 1989, Pages 1063-1066

  Heckmatt, J ^a   Saunders, C ^a   Peters, A M ^a   Rose, M ^c   Hasson, N ^a   Thompson, N ^a   Cambridge, G ^b   Hyde, S A ^a   Dubowitz, V ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United States)

^c HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

CHILD; CLINICAL ARTICLE; DERMATOMYOSITIS; HUMAN; PRIORITY JOURNAL;

CASE REPORT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYCLOSPORINS; DERMATOMYOSITIS; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMAN; PREDNISOLONE; SUPPORT, NON-U.S. GOV'T;

EID: 0024547748     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(89)92456-2     Document Type: Article

References (33)

1. Polymyositis and dermatomyositis
2. Dermatomyositis of childhood, ultrastructural alterations of muscle and intramuscular blood vessels
3. Treatment of dermatomyositis in childhood
4. Drug treatment of juvenile dermatomyositis
5. Methotreaxate and azathioprine treatment of childhood dermatomyositis
6. Azathioprine with prednisolone for polymyositis
7. Rheumatoid arthritis treatment with azathioprine (IMURAN (R)) Clinical side-effects and laboratory abnormalities
8. Acute pancreatitis following corticosteroid and azathoiprine therapy
9. Immunosuppressive agents m corticosteroid-refractory childhood dermatomyositis
10. Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases
11. Plasmapheresis in idiopathic inflammatory myopathy, experience with 35 patients
12. Childhood dermatomyositis and polymyositis, treatment with methotrexate and prednisone
13. Cyclosporin for acute dermatomyositis
14. Cyclosporine for juvenile dermatomyositis
15. Cyclosporin for polymyositis
16. Severe dermatomyositis treated with cyclosporin A
17. Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyotitis
18. The effects of cyclosporin A on the immune system
19. Effectiveness of cyclosporin therapy for Behçet's disease
20. Cyclosporin A: a review of its dermatologic applications
21. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy
22. Measurements of muscle strength and performance in children with normal and diseased muscle
23. Determinants of cyclosporin nephrotoxicity following cardiac transplantation
24. A comprehensive analysis of renal DTPA studies
25. Appropriate selection of background for Tc-99m DTPA renography
26. Stimulation of lymphokine release from T lymphoblasts Requirement for mRNA synthesis and inhibition by CSA
27. Clinical transplantation overview
28. Renal histopathologic alterations in patients treated with cyclosporin for uveitis
29. Cyclosporin-associated renal arteriopathy
30. Nephrotoxicity m bone marrow transplant recipients treated with cyclosporin-A
31. Blood cyclosporin concentrations and renal allograft dysfunction
32. Cancer after transplantation, the risks are small
33. Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy